Clinical Trials Directory

Trials / Sponsors / Amorphical Ltd.

Amorphical Ltd.

Industry · 9 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingEvaluating the Safety and Efficacy of AMOR-1 as a Treatment for Hypocalcemia Associated With Hypoparathyroidis
Hypoparathyroidism
Phase 22024-12-15
WithdrawnInvestigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of S
Castrate Resistant Prostate Cancer With Bone Metastasis
Phase 12022-06-01
CompletedSafety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) Compared to Placebo and Best Available
Covid19
Phase 1 / Phase 22021-02-09
TerminatedThe Effect of Amorphous Calcium Carbonate (ACC) Treatment on Function and Welfare in Late-stage Solid Cancer S
Oncology
Phase 12018-07-18
TerminatedImproving Function,Welfare of Late-stage Cancer Subjects by ACC
Solid Malignancies, With or Without Lung Metastases
Phase 12017-06-25
TerminatedA Study Comparing the Effect of Amorphous Calcium Carbonate (ACC) on Healing Time of Distal Radius Fractures
Distal Radius Fractures
Phase 1 / Phase 22013-06-01
TerminatedA Single Arm Study Comparing ACC Supplement to CCS in Management of Hypoparathyroidism
Hypoparathyroidism
N/A2013-04-01
CompletedA Study Comparing Amorphous Calcium Carbonate (ACC) Versus Crystalline Calcium CCS) in Hypoparathyroidism Pati
Hypoparathyroidism
Phase 1 / Phase 22013-04-01
WithdrawnAnalgesic Effects of the Gastrolith, in Osteoporotic Patients Suffering From Recent Skeletal Pain Caused by Ve
Osteoporosis
N/A2011-12-01